부산대학교 도서관

Hayes TK; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, USA.; Aquilanti E; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Persky NS; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Genetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Aera Therapeutics, Cambridge, MA, USA.; Yang X; Genetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Kim EE; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.; Brenan L; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Goodale AB; Genetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Alan D; Genetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Sharpe T; Data Science Platform, The Broad Institute of M.I.T. and Harvard Cambridge, Cambridge, MA, USA.; Shue RE; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Westlake L; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Golomb L; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Silverman BR; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.; Morris MD; Summer Honors Undergraduate Research Program, Harvard Medical School, Boston, MA, USA.; Fisher TR; Summer Honors Undergraduate Research Program, Harvard Medical School, Boston, MA, USA.; Beyene E; Summer Honors Undergraduate Research Program, Harvard Medical School, Boston, MA, USA.; Li YY; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Cherniack AD; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Piccioni F; Genetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Merck Research Laboratories, Cambridge, MA, USA.; Hicks JK; Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Chi AS; Center for Neuro-Oncology, Division of Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA.; Cahill DP; Center for Neuro-Oncology, Division of Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA.; Dietrich J; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA.; Batchelor TT; Department of Neurology, Brigham and Women's Hospital & Harvard Medical School, Boston, MA, USA.; Root DE; Genetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Johannessen CM; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Department of Oncology, Novartis Institutes for Biomedical Research, Cambridge, MA, USA.; Meyerson M; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA. matthew_meyerson@dfci.harvard.edu.; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA. matthew_meyerson@dfci.harvard.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: PubMed not MEDLINE; MEDLINE

Hayes TK; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, USA.; Aquilanti E; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Persky NS; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Genetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Aera Therapeutics, Cambridge, MA, USA.; Yang X; Genetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Kim EE; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.; Brenan L; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Goodale AB; Genetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Alan D; Genetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Sharpe T; Data Science Platform, The Broad Institute of M.I.T. and Harvard Cambridge, Cambridge, MA, USA.; Shue RE; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Westlake L; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Golomb L; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Silverman BR; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.; Morris MD; Summer Honors Undergraduate Research Program, Harvard Medical School, Boston, MA, USA.; Fisher TR; Summer Honors Undergraduate Research Program, Harvard Medical School, Boston, MA, USA.; Beyene E; Summer Honors Undergraduate Research Program, Harvard Medical School, Boston, MA, USA.; Li YY; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Cherniack AD; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Piccioni F; Genetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Merck Research Laboratories, Cambridge, MA, USA.; Hicks JK; Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Chi AS; Center for Neuro-Oncology, Division of Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA.; Cahill DP; Center for Neuro-Oncology, Division of Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA.; Dietrich J; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA.; Batchelor TT; Department of Neurology, Brigham and Women's Hospital & Harvard Medical School, Boston, MA, USA.; Root DE; Genetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Johannessen CM; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Department of Oncology, Novartis Institutes for Biomedical Research, Cambridge, MA, USA.; Meyerson M; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA. matthew_meyerson@dfci.harvard.edu.; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA. matthew_meyerson@dfci.harvard.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Rees MG; Broad Institute of MIT and Harvard, Cambridge, MA, USA. reesm@broadinstitute.org.; Brenan L; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; do Carmo M; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Duggan P; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Mayo Clinic Alix School of Medicine, Rochester, MN, USA.; Bajrami B; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Arciprete M; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Boghossian A; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Vaimberg E; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Johns Hopkins Hospital, Department of Pediatrics, Baltimore, MD, USA.; Ferrara SJ; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Lewis TA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Rosenberg D; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Sangpo T; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Roth JA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Kaushik VK; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Piccioni F; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Merck Research Laboratories, Cambridge, MA, USA.; Doench JG; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Root DE; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Johannessen CM; Broad Institute of MIT and Harvard, Cambridge, MA, USA. johannes@broadinstitute.org.; Novartis Institutes for BioMedical Research, Cambridge, MA, USA. johannes@broadinstitute.org.

Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101231976 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4469 (Electronic) Linking ISSN: 15524450 NLM ISO Abbreviation: Nat Chem Biol Subsets: MEDLINE

Ito T; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Scorpion Therapeutics, Boston, MA, USA.; Young MJ; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Li R; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Jain S; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Wernitznig A; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.; Krill-Burger JM; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Lemke CT; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Monducci D; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Rodriguez DJ; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Chang L; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Dutta S; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Pal D; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Paolella BR; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Rothberg MV; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Root DE; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Johannessen CM; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Oncology, Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Parida L; IBM Research, T.J. Watson Research Center, Yorktown Heights, NY, USA.; Getz G; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Cancer Center and Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.; Vazquez F; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Doench JG; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Zamanighomi M; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Sellers WR; Broad Institute of Harvard and MIT, Cambridge, MA, USA. wsellers@broadinstitute.org.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. wsellers@broadinstitute.org.; Harvard Medical School, Boston, MA, USA. wsellers@broadinstitute.org.

Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE

Calvo JA; Department of Molecular Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts.; Fritchman B; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Hernandez D; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Persky NS; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Johannessen CM; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Piccioni F; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Kelch BA; Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts.; Cantor SB; Department of Molecular Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts. Sharon.Cantor@umassmed.edu.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101150042 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3125 (Electronic) Linking ISSN: 15417786 NLM ISO Abbreviation: Mol Cancer Res Subsets: MEDLINE

Feldman D; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.; Department of Physics, MIT, Cambridge, MA, 02142, USA.; Tsai F; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.; Present address: 10x Genomics, Pleasanton, CA, 94588, USA.; Garrity AJ; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.; Present address: Arbor Biotechnologies, Cambridge, MA, 02140, USA.; O'Rourke R; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.; Present address: Casma Therapeutics, Cambridge, MA, 02139, USA.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, 02115, USA.; Brenan L; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.; Ho P; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, 02115, USA.; Gonzalez E; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, 02115, USA.; Konermann S; Salk Institute, La Jolla, CA, 92037, USA.; Johannessen CM; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA. johannes@broadinstitute.org.; Present address: Novartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA. johannes@broadinstitute.org.; Beroukhim R; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA. rameen@broadinstitute.org.; Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA. rameen@broadinstitute.org.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA. rameen@broadinstitute.org.; Bandopadhayay P; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA. pratiti_bandopadhayay@dfci.harvard.edu.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, 02115, USA. pratiti_bandopadhayay@dfci.harvard.edu.; Department of Pediatrics, Harvard Medical School, Boston, MA, 02115, USA. pratiti_bandopadhayay@dfci.harvard.edu.; Blainey PC; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA. pblainey@broadinstitute.org.; Department of Biological Engineering, MIT, Cambridge, MA, 02142, USA. pblainey@broadinstitute.org.; Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, 02142, USA. pblainey@broadinstitute.org.

Publisher: BioMed Central Country of Publication: England NLM ID: 101190720 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7007 (Electronic) Linking ISSN: 17417007 NLM ISO Abbreviation: BMC Biol Subsets: MEDLINE

Howard TP; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Oberlick EM; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Rees MG; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Arnoff TE; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Pham MT; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Brenan L; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; DoCarmo M; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Hong AL; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Department of Pediatrics, Emory University, Atlanta, Georgia.; Kugener G; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Chou HC; Comprehensive Cancer Center, St. Jude Children's Research Hospital, Memphis, Tennessee.; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.; Drosos Y; Comprehensive Cancer Center, St. Jude Children's Research Hospital, Memphis, Tennessee.; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.; Mathias KM; Comprehensive Cancer Center, St. Jude Children's Research Hospital, Memphis, Tennessee.; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.; Ramos P; Comprehensive Cancer Center, St. Jude Children's Research Hospital, Memphis, Tennessee.; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.; Seashore-Ludlow B; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Giacomelli AO; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Wang X; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts.; Department of Molecular and Systems Biology, Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire.; Freeman BB 3rd; Preclinical Pharmacokinetics Shared Resource, St. Jude Children's Research Hospital, Memphis, Tennessee.; Blankenship K; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.; Hoffmann L; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.; Tiv HL; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Gokhale PC; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Johannessen CM; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Stewart EA; Comprehensive Cancer Center, St. Jude Children's Research Hospital, Memphis, Tennessee. charles.roberts@stjude.org elizabeth.stewart@stjude.org william_hahn@dfci.harvard.edu.; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.; Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, Tennessee.; Schreiber SL; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts.; Hahn WC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. charles.roberts@stjude.org elizabeth.stewart@stjude.org william_hahn@dfci.harvard.edu.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Roberts CWM; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts. charles.roberts@stjude.org elizabeth.stewart@stjude.org william_hahn@dfci.harvard.edu.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Comprehensive Cancer Center, St. Jude Children's Research Hospital, Memphis, Tennessee.; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.

Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Bolan PO; Weill Cornell Medicine, New York, NY 10065, USA.; Zviran A; Division of Hematology and Medical Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10065, USA; New York Genome Center, New York, NY 10013, USA; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY 10065, USA.; Brenan L; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Schiffman JS; Division of Hematology and Medical Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10065, USA; New York Genome Center, New York, NY 10013, USA; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY 10065, USA.; Dusaj N; Weill Cornell Medicine, New York, NY 10065, USA.; Goodale A; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Piccioni F; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Johannessen CM; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Electronic address: johannes@broadinstitute.org.; Landau DA; Division of Hematology and Medical Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10065, USA; New York Genome Center, New York, NY 10013, USA; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY 10065, USA. Electronic address: dlandau@nygenome.org.

Publisher: Cell Press Country of Publication: United States NLM ID: 101656080 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2405-4720 (Electronic) Linking ISSN: 24054712 NLM ISO Abbreviation: Cell Syst Subsets: MEDLINE

Persky NS; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Hernandez D; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Do Carmo M; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Brenan L; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Cohen O; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Kitajima S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Nayar U; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Walker A; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Pantel S; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Lee Y; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Cordova J; University of New Mexico, Albuquerque, NM, USA.; Sathappa M; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Zhu C; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Hayes TK; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Ram P; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Pancholi P; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Mikkelsen TS; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.; 10x Genomics, Inc., Pleasanton, CA, USA.; Barbie DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Yang X; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Haq R; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Piccioni F; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Root DE; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Johannessen CM; The Broad Institute of MIT and Harvard, Cambridge, MA, USA. johannes@broadinstitute.org.; Oncology, Novartis Institutes for BioMedical Research, Cambridge, MA, USA. johannes@broadinstitute.org.

Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101186374 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-9985 (Electronic) Linking ISSN: 15459985 NLM ISO Abbreviation: Nat Struct Mol Biol Subsets: MEDLINE

Stover EH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Baco MB; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Cohen O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Li YY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Christie EL; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia.; Bagul M; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Goodale A; Genetic Perturbation Platform, Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Lee Y; Genetic Perturbation Platform, Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Pantel S; Genetic Perturbation Platform, Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Rees MG; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Wei G; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Presser AG; John B. Little Center for Radiation Sciences, Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Gelbard MK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Zhang W; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Zervantonakis IK; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts.; Bhola PD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Ryan J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Guerriero JL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Montero J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Institute for Bioengineering of Catalonia, Barcelona, Spain.; Liang FJ; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Cherniack AD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Piccioni F; Genetic Perturbation Platform, Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Matulonis UA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Bowtell DDL; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia.; Sarosiek KA; John B. Little Center for Radiation Sciences, Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Letai A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Garraway LA; Eli Lilly and Company, Indianapolis, Indiana.; Johannessen CM; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Meyerson M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. matthew_meyerson@dfci.harvard.edu.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101150042 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3125 (Electronic) Linking ISSN: 15417786 NLM ISO Abbreviation: Mol Cancer Res Subsets: MEDLINE